|
Market Closed -
Nasdaq
04:00:00 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 244.05 USD | -3.43% |
|
+1.27% | +38.67% |
| Oct. 28 | Health Care Up as Traders Slough Off Earnings -- Health Care Roundup | DJ |
| Oct. 28 | Biogen tops quarterly estimates on rare-disease drug strength | RE |
| Market Cap | 36.08B 32.37B 29.92B 27.1B 50.63B 3,436B 51.25B 358B 143B 1,798B 135B 133B 5,708B | P/E 2026 * |
40.6x | P/E 2027 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise Value | 41.02B 36.8B 34.03B 30.82B 57.57B 3,907B 58.27B 407B 162B 2,044B 154B 151B 6,490B | EV / Sales 2026 * |
3.93x | EV / Sales 2027 * | 3.61x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | -3.43% | ||
| 1 week | +1.27% | ||
| Current month | +8.04% | ||
| 1 month | +6.72% | ||
| 3 months | +18.70% | ||
| 6 months | +33.08% | ||
| Current year | +38.67% |
| 1 week | 243.03 |  | 258.78 |
| 1 month | 215.73 | | 258.78 |
| Current year | 160.36 | | 258.78 |
| 1 year | 138 | | 258.78 |
| 3 years | 110.04 | | 268.3 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2022-11-13 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 2025-02-28 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 2010-03-22 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 2009-12-31 |
William Hawkins
BRD | Director/Board Member | 72 | 2019-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/2/26 | Exercice | Controller/Auditor | 62 | 0.0000% | ||
| 9/1/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 8/4/26 | Sell | Director | -593 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.43% | +1.27% | +63.65% | +4.06% | 37.34B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | -0.20% | +1.16% | +42.94% | +69.17% | 406.49B | |
| Weighted average by Cap. | +0.22% | +0.74% | +44.67% | +88.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 9.37B 8.67B 7.85B 14.67B 995B 14.84B 104B 41.28B 521B 39.21B 38.38B 1,653B | 10.65B 9.56B 8.83B 8B 14.95B 1,014B 15.13B 106B 42.07B 531B 39.97B 39.12B 1,685B |
| Net income | 1B 899M 831M 753M 1.41B 95.45B 1.42B 9.94B 3.96B 49.95B 3.76B 3.68B 159B | 1.8B 1.62B 1.5B 1.35B 2.53B 172B 2.56B 17.88B 7.12B 89.86B 6.77B 6.62B 285B |
| Net Debt | 4.94B 4.44B 4.1B 3.71B 6.94B 471B 7.02B 49.04B 19.53B 246B 18.56B 18.16B 782B | 2.4B 2.15B 1.99B 1.8B 3.36B 228B 3.4B 23.77B 9.47B 119B 8.99B 8.8B 379B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | $244.05 | -3.43% | 2,323,982 |
| 26-10-27 | $252.73 | +0.19% | 1,393,391 |
| 26-10-26 | $252.26 | +0.63% | 958,847 |
| 26-10-23 | $250.69 | -1.24% | 1,157,376 |
| 26-10-22 | $253.84 | +5.34% | 2,237,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
